4/9
12:09 pm
lipo
Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) is now covered by analysts at Maxim Group. They set a "buy" rating and a $2.00 price target on the stock.
Low
Report
Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) is now covered by analysts at Maxim Group. They set a "buy" rating and a $2.00 price target on the stock.
4/9
11:35 am
lipo
Rating for LIPO
Low
Report
Rating for LIPO
4/9
07:34 am
lipo
Lipella Pharmaceuticals initiated with bullish view at Maxim
Medium
Report
Lipella Pharmaceuticals initiated with bullish view at Maxim